Otsuka (OTCMKTS:OTSKY) Trading Down 3.8% - Here's Why

Key Points

• Otsuka Holdings Co., Ltd. shares declined by 3.8%, closing at $27.70, significantly below its previous close of $28.80.
• The stock is rated a "strong sell" by Zacks Research, and has a consensus rating of "Sell" from analysts.
• Otsuka has a market cap of $29.79 billion and a remarkably low price-to-earnings ratio of 0.18.

Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTCMKTS:OTSKY - Get Free Report)'s stock price traded down 3.8% on Wednesday . The stock traded as low as $27.70 and last traded at $27.70. 2,764 shares traded hands during trading, a decline of 95% from the average session volume of 52,009 shares. The stock had previously closed at $28.80.

Analyst Ratings Changes

Separately, Zacks Research upgraded Otsuka to a "strong sell" rating in a report on Monday, August 11th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Otsuka currently has an average rating of "Sell".

Otsuka Stock Down 0.9%

The company has a market capitalization of $29.56 billion and a price-to-earnings ratio of 0.18. The business has a 50-day moving average price of $25.87 and a two-hundred day moving average price of $25.02.

About Otsuka

Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.